IL123171A - Process for the preparation of substituted 2-oxazolidinone derivatives and a non-solvated 2-oxazolidinone derivative - Google Patents
Process for the preparation of substituted 2-oxazolidinone derivatives and a non-solvated 2-oxazolidinone derivativeInfo
- Publication number
- IL123171A IL123171A IL12317196A IL12317196A IL123171A IL 123171 A IL123171 A IL 123171A IL 12317196 A IL12317196 A IL 12317196A IL 12317196 A IL12317196 A IL 12317196A IL 123171 A IL123171 A IL 123171A
- Authority
- IL
- Israel
- Prior art keywords
- oxazolidinone
- solvated
- substituted
- preparation
- derivative
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D263/18—Oxygen atoms
- C07D263/20—Oxygen atoms attached in position 2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C271/06—Esters of carbamic acids
- C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
- C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C271/20—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by nitrogen atoms not being part of nitro or nitroso groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C271/06—Esters of carbamic acids
- C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
- C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C271/22—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by carboxyl groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Indole Compounds (AREA)
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IL156733A IL156733A (en) | 1995-08-07 | 1996-08-02 | Process for the preparation of 2-oxazolidinone derivatives, intermediates for such a process and their preparation and use in the preparation of preparations for medical use |
IL14803002A IL148030A0 (en) | 1995-08-07 | 2002-02-06 | Process for the purification of (s)-4-{[3-(dimethylamino)ethyl]-1h-indol-5-yl] methyl}-2-oxazolidinone |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9516145.1A GB9516145D0 (en) | 1995-08-07 | 1995-08-07 | Improved chemical synthesis |
PCT/GB1996/001885 WO1997006162A1 (en) | 1995-08-07 | 1996-08-02 | One pot synthesis of 2-oxazolidinone derivatives |
Publications (2)
Publication Number | Publication Date |
---|---|
IL123171A0 IL123171A0 (en) | 1998-09-24 |
IL123171A true IL123171A (en) | 2003-10-31 |
Family
ID=10778867
Family Applications (4)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL156733A IL156733A (en) | 1995-08-07 | 1996-08-02 | Process for the preparation of 2-oxazolidinone derivatives, intermediates for such a process and their preparation and use in the preparation of preparations for medical use |
IL12317196A IL123171A (en) | 1995-08-07 | 1996-08-02 | Process for the preparation of substituted 2-oxazolidinone derivatives and a non-solvated 2-oxazolidinone derivative |
IL148030A IL148030A (en) | 1995-08-07 | 1996-08-02 | Process for purification (S) - 4 - {[3 - (2 - (dimethylamino) ethyl] - H1 - indole - 5 - ile] methyl} -2 - oxazolidinone |
IL14803002A IL148030A0 (en) | 1995-08-07 | 2002-02-06 | Process for the purification of (s)-4-{[3-(dimethylamino)ethyl]-1h-indol-5-yl] methyl}-2-oxazolidinone |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL156733A IL156733A (en) | 1995-08-07 | 1996-08-02 | Process for the preparation of 2-oxazolidinone derivatives, intermediates for such a process and their preparation and use in the preparation of preparations for medical use |
Family Applications After (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL148030A IL148030A (en) | 1995-08-07 | 1996-08-02 | Process for purification (S) - 4 - {[3 - (2 - (dimethylamino) ethyl] - H1 - indole - 5 - ile] methyl} -2 - oxazolidinone |
IL14803002A IL148030A0 (en) | 1995-08-07 | 2002-02-06 | Process for the purification of (s)-4-{[3-(dimethylamino)ethyl]-1h-indol-5-yl] methyl}-2-oxazolidinone |
Country Status (34)
Country | Link |
---|---|
US (2) | US6084103A (xx) |
EP (2) | EP0843672B1 (xx) |
JP (6) | JP3729503B2 (xx) |
KR (1) | KR100670704B1 (xx) |
CN (3) | CN1092657C (xx) |
AR (2) | AR006515A1 (xx) |
AT (2) | ATE325121T1 (xx) |
AU (1) | AU718413B2 (xx) |
BR (1) | BR9609830A (xx) |
CA (2) | CA2572508C (xx) |
CZ (2) | CZ293050B6 (xx) |
DE (2) | DE69636107T2 (xx) |
DK (2) | DK1227095T3 (xx) |
ES (2) | ES2261545T3 (xx) |
GB (1) | GB9516145D0 (xx) |
HK (2) | HK1047094B (xx) |
HU (1) | HU229966B1 (xx) |
IL (4) | IL156733A (xx) |
IN (2) | IN185148B (xx) |
MX (1) | MX9801044A (xx) |
MY (1) | MY117571A (xx) |
NO (2) | NO311690B1 (xx) |
NZ (1) | NZ315040A (xx) |
PL (1) | PL188805B1 (xx) |
PT (2) | PT843672E (xx) |
RO (2) | RO121816B1 (xx) |
RU (1) | RU2167875C2 (xx) |
SI (2) | SI0843672T1 (xx) |
SK (1) | SK285052B6 (xx) |
TR (1) | TR199800182T1 (xx) |
TW (1) | TW358811B (xx) |
UA (1) | UA53625C2 (xx) |
WO (1) | WO1997006162A1 (xx) |
ZA (1) | ZA966711B (xx) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001004088A1 (fr) * | 1999-07-09 | 2001-01-18 | Chugai Seiyaku Kabushiki Kaisha | Procede de preparation de derives d'amiline |
ES2204302B2 (es) * | 2002-08-07 | 2005-03-01 | Laboratorios Vita, S.A. | Procedimiento para la obtencion de un compuesto farmaceuticamente activo. |
US20070173536A1 (en) * | 2004-02-06 | 2007-07-26 | Ciba Specialty Chemicals Holding Inc. | Crystalline forms of zolmitriptan |
EP1812428A2 (en) * | 2004-11-19 | 2007-08-01 | Teva Pharmaceutical Industries Ltd | Zolmitriptan crystal forms |
CN101248184B (zh) | 2005-08-25 | 2013-01-16 | 宇部兴产株式会社 | 光学活性(S或R)-α-氨基酸及光学活性(S或R)-α-氨基酸酯的制造方法 |
EP1981860B1 (en) | 2006-01-19 | 2011-05-25 | Matrix Laboratories Ltd | Conversion of aromatic diazonium salt to aryl hydrazine |
WO2008007390A2 (en) * | 2006-07-10 | 2008-01-17 | Natco Pharma Limited | An improved process for purification of zolmitriptan |
WO2008018090A2 (en) * | 2006-08-09 | 2008-02-14 | Matrix Laboratories Ltd | An improved process for the preparation of zolmitriptan |
CZ2007158A3 (cs) * | 2007-02-26 | 2008-10-22 | Zentiva, A. S. | Zpusob prípravy zolmitriptanu |
CZ301538B6 (cs) | 2007-02-26 | 2010-04-07 | Zentiva, A. S. | Zpusob prípravy zolmitriptanu |
JP2010540613A (ja) * | 2007-10-03 | 2010-12-24 | ジェネリクス・(ユーケー)・リミテッド | ゾルミトリプタン、その塩、及びその溶媒和物の調製方法 |
CN101230047B (zh) * | 2008-02-04 | 2010-08-04 | 江苏中威药业有限公司 | 一种4-取代手性噁唑烷酮类化合物的制备方法 |
US8906949B2 (en) | 2010-05-21 | 2014-12-09 | Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi | Orally disintegrating tablets of zolmitriptan and process for preparing the same |
CN101948443B (zh) * | 2010-08-17 | 2012-08-22 | 河南师范大学 | 一种简单、高效合成4-取代噁唑烷酮衍生物的方法 |
WO2012135615A2 (en) | 2011-03-30 | 2012-10-04 | Brown University | Enopeptins, uses thereof, and methods of synthesis thereto |
WO2013057739A2 (en) * | 2011-09-02 | 2013-04-25 | Emcure Pharmaceuticals Limited | An improved process for preparation of zolmitriptan |
CN102964270B (zh) * | 2012-11-21 | 2015-01-07 | 合肥星宇化学有限责任公司 | 一种亚硫酸钠还原重氮盐合成肼的方法 |
CN103275075B (zh) * | 2013-06-24 | 2015-01-07 | 成都天台山制药有限公司 | 佐米曲普坦及其制备方法 |
WO2016037072A2 (en) * | 2014-09-04 | 2016-03-10 | Brown University | Enopeptin analogas and methods of use thereof |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8724912D0 (en) * | 1987-10-23 | 1987-11-25 | Wellcome Found | Indole derivatives |
MC2210A1 (fr) * | 1990-06-07 | 1992-11-26 | Wellcome Found | Composes heterocycliques therapeutiques,leur utilisation et procede pour les preparer |
GB9401436D0 (en) * | 1994-01-26 | 1994-03-23 | Wellcome Found | Therapeutic heterocyclic compounds |
GB9423682D0 (en) * | 1994-11-23 | 1995-01-11 | Merck Sharp & Dohme | Therapeutic agents |
JPH10509721A (ja) * | 1994-12-06 | 1998-09-22 | メルク シヤープ エンド ドーム リミテツド | 5ht1レセプターアゴニストとしてのアゼチジン、ピロリジン及びピペリジン誘導体 |
-
1995
- 1995-08-07 GB GBGB9516145.1A patent/GB9516145D0/en active Pending
-
1996
- 1996-02-08 UA UA98031096A patent/UA53625C2/uk unknown
- 1996-08-02 SK SK154-98A patent/SK285052B6/sk not_active IP Right Cessation
- 1996-08-02 DK DK02008427T patent/DK1227095T3/da active
- 1996-08-02 IL IL156733A patent/IL156733A/en not_active IP Right Cessation
- 1996-08-02 PT PT96926465T patent/PT843672E/pt unknown
- 1996-08-02 EP EP96926465A patent/EP0843672B1/en not_active Expired - Lifetime
- 1996-08-02 NZ NZ315040A patent/NZ315040A/xx not_active IP Right Cessation
- 1996-08-02 PL PL96324881A patent/PL188805B1/pl unknown
- 1996-08-02 HU HU9900188A patent/HU229966B1/hu unknown
- 1996-08-02 KR KR1019980700833A patent/KR100670704B1/ko not_active IP Right Cessation
- 1996-08-02 WO PCT/GB1996/001885 patent/WO1997006162A1/en not_active Application Discontinuation
- 1996-08-02 JP JP50822697A patent/JP3729503B2/ja not_active Expired - Lifetime
- 1996-08-02 MX MX9801044A patent/MX9801044A/es unknown
- 1996-08-02 US US09/011,045 patent/US6084103A/en not_active Expired - Lifetime
- 1996-08-02 BR BR9609830A patent/BR9609830A/pt not_active Application Discontinuation
- 1996-08-02 ES ES02008427T patent/ES2261545T3/es not_active Expired - Lifetime
- 1996-08-02 AT AT02008427T patent/ATE325121T1/de active
- 1996-08-02 DE DE69636107T patent/DE69636107T2/de not_active Expired - Lifetime
- 1996-08-02 AT AT96926465T patent/ATE227723T1/de active
- 1996-08-02 SI SI9630560T patent/SI0843672T1/xx unknown
- 1996-08-02 ES ES96926465T patent/ES2185790T3/es not_active Expired - Lifetime
- 1996-08-02 TR TR1998/00182T patent/TR199800182T1/xx unknown
- 1996-08-02 CA CA2572508A patent/CA2572508C/en not_active Expired - Lifetime
- 1996-08-02 IL IL12317196A patent/IL123171A/xx not_active IP Right Cessation
- 1996-08-02 DE DE69624825T patent/DE69624825T2/de not_active Expired - Lifetime
- 1996-08-02 PT PT02008427T patent/PT1227095E/pt unknown
- 1996-08-02 DK DK96926465T patent/DK0843672T3/da active
- 1996-08-02 CN CN96197237A patent/CN1092657C/zh not_active Expired - Lifetime
- 1996-08-02 CZ CZ1998352A patent/CZ293050B6/cs not_active IP Right Cessation
- 1996-08-02 IL IL148030A patent/IL148030A/en not_active IP Right Cessation
- 1996-08-02 CN CNB011330929A patent/CN1244579C/zh not_active Expired - Lifetime
- 1996-08-02 EP EP02008427A patent/EP1227095B1/en not_active Expired - Lifetime
- 1996-08-02 SI SI9630738T patent/SI1227095T1/sl unknown
- 1996-08-02 RU RU98104085/04A patent/RU2167875C2/ru active
- 1996-08-02 RO ROA200400914A patent/RO121816B1/ro unknown
- 1996-08-02 CZ CZ20031498A patent/CZ301603B6/cs not_active IP Right Cessation
- 1996-08-02 CN CNB01112010XA patent/CN1142904C/zh not_active Expired - Lifetime
- 1996-08-02 CA CA002227039A patent/CA2227039C/en not_active Expired - Lifetime
- 1996-08-02 AU AU66634/96A patent/AU718413B2/en not_active Expired
- 1996-08-02 RO RO98-00214A patent/RO119618B1/ro unknown
- 1996-08-06 IN IN1742DE1996 patent/IN185148B/en unknown
- 1996-08-06 MY MYPI96003220A patent/MY117571A/en unknown
- 1996-08-07 AR ARP960103909A patent/AR006515A1/es active IP Right Grant
- 1996-08-07 ZA ZA9606711A patent/ZA966711B/xx unknown
- 1996-10-01 TW TW085111923A patent/TW358811B/zh not_active IP Right Cessation
-
1998
- 1998-02-06 NO NO19980522A patent/NO311690B1/no not_active IP Right Cessation
- 1998-08-19 HK HK02108548.8A patent/HK1047094B/zh not_active IP Right Cessation
- 1998-08-19 HK HK98110000A patent/HK1009129A1/xx not_active IP Right Cessation
-
2000
- 2000-02-02 US US09/496,409 patent/US6160123A/en not_active Expired - Lifetime
- 2000-04-25 IN IN454DE2000 patent/IN189756B/en unknown
- 2000-10-16 NO NO20005187A patent/NO311691B1/no not_active IP Right Cessation
-
2001
- 2001-07-27 JP JP2001228781A patent/JP2002037786A/ja not_active Withdrawn
- 2001-07-27 JP JP2001228782A patent/JP3739678B2/ja not_active Expired - Lifetime
-
2002
- 2002-02-06 IL IL14803002A patent/IL148030A0/xx unknown
- 2002-03-26 JP JP2002086955A patent/JP2002308858A/ja not_active Withdrawn
-
2003
- 2003-05-02 AR ARP030101543A patent/AR046236A2/es active IP Right Grant
-
2005
- 2005-11-18 JP JP2005334990A patent/JP4634286B2/ja not_active Expired - Lifetime
-
2006
- 2006-05-31 JP JP2006152810A patent/JP2006225406A/ja not_active Withdrawn
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL123171A (en) | Process for the preparation of substituted 2-oxazolidinone derivatives and a non-solvated 2-oxazolidinone derivative | |
IL115315A (en) | Process for the preparation of non-solvated crystalline forms of benzothiophene derivatives | |
IL117659A0 (en) | Acetamide derivative process for preparing the same and a pharmaceutical composition containing the same | |
EG25852A (en) | Teracyclic derivatives process of preparation | |
PL322277A1 (en) | Derivatives of pyrazol-4-ylobenzoyl | |
HUP9901085A3 (en) | A process for preparing aza-cyclohexapeptide derivatives | |
HUP9900947A3 (en) | Process for the preparation of piperidine derivatives, intermediates and preparation thereof | |
PL324451A1 (en) | Derivatives of diphenylmethylenepiperidine | |
HUP9900318A3 (en) | Process for preparing 4-aryl-piperidine derivatives | |
AU5898596A (en) | A process for the preparation of lercanidipine hydrochloride | |
GR3032600T3 (en) | Process for the production of imidazo-benzodiazepine derivatives | |
HUP9904034A3 (en) | New process for the preparation of phenylimidazolidine derivatives | |
PL325517A1 (en) | Derivatives of benzothiazolone | |
EP0722949A3 (en) | Process for the preparation of cyclopentadienyl compounds and compounds produced by the process | |
HUP9903701A3 (en) | Process for the preparation of 2-chlorothiazole derivatives, intermediates and preparation thereof | |
IL117574A0 (en) | Processes for the preparation of cyclobutanone derivatives | |
HUP9903481A3 (en) | Process for the preparation of 1-aryl-1-cyanocyclobutane derivatives | |
IL118992A0 (en) | Process and intermediates for preparing norbenzomorphan derivatives | |
EG20800A (en) | Process for preparing of benzophenonehudazone derivatives and insecticides | |
SG44059A1 (en) | Process for preparing acetoxyazetidinone derivative and intermediate thereof | |
EG21612A (en) | Process for preparing of naphtoqunone derivatives | |
EP0752419A3 (de) | Verfahren zur Herstellung von N-substituierten 4-Ketoprolin-Derivaten | |
AU4191396A (en) | A process for the preparation of benzimidazole derivatives | |
AU1163795A (en) | Hirudin derivatives and a process for their preparation | |
ZA968604B (en) | A process for the preparation of alpha-chloromethylphenyl-acetic acid derivatives |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FF | Patent granted | ||
KB | Patent renewed | ||
KB | Patent renewed | ||
KB | Patent renewed | ||
KB | Patent renewed | ||
EXP | Patent expired |